Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FYM44
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,296
Award facts
- Contract value 100% obligated
- $49,296.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,296.01 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group was selected as the prime contractor with no identified subcontractors on this award.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs for Department of Defense healthcare facilities worldwide. The parent IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and positions DMS Pharmaceutical Group as a critical regional prime vendor contractor for the military healthcare system. The company's established track record supplying diverse pharmaceutical products—including specialty medications, biologics, vaccines, and medical devices—demonstrates its capability to fulfill the specialized requirements of federal military medical operations.
Quick answers
Who was awarded contract SPE2DB26FYM44?
SPE2DB26FYM44 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FYM44 worth?
The government has obligated $49,296 on SPE2DB26FYM44.
Is contract SPE2DB26FYM44 an order under another contract?
Yes. SPE2DB26FYM44 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB26FYM44 competed?
The extent of competition for SPE2DB26FYM44 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award